Zero cervical cancer deaths in young English women linked to HPV vaccine milestone

New data from England shows that no women aged 20 to 24 died from cervical cancer between 2020 and 2024, a first recorded milestone that researchers attribute directly to the HPV vaccine program. The vaccine, introduced in English schools in 2008, has led to a dramatic drop in deaths among vaccinated young women, according to a landmark study reported by the BBC.

"This is a triumph for vaccination, science and public health."

The findings provide the first direct evidence that the HPV vaccine prevents deaths from cervical cancer, New Scientist reported. Experts described the results as stunning, noting that girls vaccinated at age 12 to 13 now face close to zero risk of dying from the disease before age 30. The BBC estimated that around 200 lives have been saved in England so far, with projections suggesting over 400 lives could be saved per year by 2050.

"The study provides the first direct evidence of the vaccine's life-saving impact."

This milestone represents a significant public health achievement, with both outlets emphasizing the vaccine's role in nearly eliminating cervical cancer deaths among vaccinated young women. The data underscores the long-term effectiveness of the vaccination program, which began over a decade ago, and offers a powerful example of preventive medicine's potential to save lives.